Endothelin receptors as a potential therapeutic target in the treatment of cardiovascular disease: Rationale for selective antagonism of the ET(A) subtype

被引：0
|
作者：
Webb, ML
Liu, ECK
Aversa, CR
Spinale, FG
Russell, ME
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT CARDIOVASC BIOCHEM,PRINCETON,NJ 08543
[2] MED UNIV S CAROLINA,DIV CARDIOTHORAC SURG,CHARLESTON,SC 29425
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT MED,SCH MED,BOSTON,MA 02115
来源：
DRUG NEWS & PERSPECTIVES | 1996年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [1] The endothelin system and its potential as a therapeutic target in cardiovascular disease
    Gray, GA
    Webb, DJ
    PHARMACOLOGY & THERAPEUTICS, 1996, 72 (02) : 109 - 148
  • [2] Selective and mixed endothelin receptor antagonism in cardiovascular disease
    Dhaun, Neeraj
    Pollock, David M.
    Goddard, Jane
    Webb, David J.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (11) : 573 - 579
  • [3] Endothelin receptors as drug targets in chronic cardiovascular diseases: The rationale for dual antagonism
    Clozel, Martine
    Flores, Susan
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (11) : 825 - 834
  • [4] Therapeutic potential of endothelin receptor antagonism in kidney disease
    Czopek, Alicja
    Moorhouse, Rebecca
    Webb, David J.
    Dhaun, Neeraj
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2016, 310 (05) : R388 - R397
  • [5] Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease
    Stephen, Sam L.
    Freestone, Katie
    Dunn, Sarah
    Twigg, Michael W.
    Homer-Vanniasinkam, Shervanthi
    Walker, John H.
    Wheatcroft, Stephen B.
    Ponnambalam, Sreenivasan
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2010, 2010
  • [6] Toll-like receptors as a potential therapeutic target for atherosclerosis and cardiovascular disease
    Lacheta, Dominika
    Olejarz, Wioletta
    Wrzosek, Malgorzata
    Nowicka, Grazyna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 728 - 739
  • [7] The therapeutic potential of endothelin receptor antagonists in cardiovascular disease
    Barton M.
    Kiowski W.
    Current Hypertension Reports, 2001, 3 (4) : 322 - 330
  • [8] The endothelin system as target for therapeutic interventions in cardiovascular and renal disease
    Eroglu, Eray
    Kocyigit, Ismail
    Lindholm, Bengt
    CLINICA CHIMICA ACTA, 2020, 506 : 92 - 106
  • [9] Osteopontin in Cardiovascular Disease A Potential Therapeutic Target
    Waller, Alfonso H.
    Sanchez-Ross, Monica
    Kaluski, Edo
    Klapholz, Marc
    CARDIOLOGY IN REVIEW, 2010, 18 (03) : 125 - 131
  • [10] Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease
    Parizadeh, Seyed Mostafa
    Ghandehari, Maryam
    Heydari-majd, Motahareh
    Seifi, Sima
    Mardani, Ramin
    Parizadeh, Seyed Mohamadreza
    Ghayour-Mobarhan, Majid
    Ferns, Gordon A.
    Hassanian, Seyed Mahdi
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (17) : 1893 - 1904
12345